Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools GIST

GIST

Programs, trials, and reported response and survival for gastrointestinal stromal tumor.

Data as of 11.07.2026

All studies

Avapritinib

VOYAGER

Blueprint Medicines · Phase 3 · Completed · Enrollment 476

NCT03465722

ArmReported safety
Avapritinib 300 mgn/r
Regorafenib 160 mgn/r

A count stays a count. This page does not turn a count into a percent.